MedicarePartD.guide

A non-government resource built from CMS public data

TNF blockers on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
TNF blockers by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
HumiraadalimumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 52/365dNot coveredNot covered
adalimumab biosimilarsadalimumab-adaz, -fkjp, -aacf and othersTier 5PA25%QL 0.2/28dTier 5PA25%QL 4/28dTier 5PA25%QL 4/28dTier 5PA26%QL 0.2/28dNot coveredTier 5PA25%Not coveredNot coveredTier 5PA31%Tier 5PA33%QL 0.2/28d
Hadlimaadalimumab-bwwdNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 2.4/28dNot coveredTier 5PA25%QL 2.4/28dTier 5PA25%QL 22.4/365dNot coveredNot covered
Hyrimozadalimumab-adazNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Cyltezoadalimumab-adbmNot coveredTier 5PA25%QL 4/28dTier 5PA25%QL 4/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Simlandiadalimumab-ryvkNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Yuflymaadalimumab-aatyNot coveredTier 5PA25%QL 2/28dTier 5PA25%QL 2/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Amjevitaadalimumab-attoNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
EnbreletanerceptTier 5PA25%QL 8/28dTier 5PA25%QL 8/28dTier 5PA25%QL 8/28dTier 5PA26%QL 8/28dTier 5PA25%QL 8/28dTier 5PA25%QL 4/28dTier 5PA25%QL 8/28dTier 5PA25%QL 8/28dTier 5PA31%QL 4/28dTier 5PA33%QL 8/28d
Cimziacertolizumab pegolNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SimponigolimumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.